EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study

Miloš Veljković iD, Slobodanka Beatović, Tomislav Pejčić, Zoran Bukumirić iD, Strahinja Odalović, Isidora Grozdić-Milojević iD, Milica Stojiljković iD, Jelena Petrović iD, Ana Ivanovski iD, Dragana Šobić-Šaranović iD, Vera Artiko iD

Diagnostics · 18.03.2026 · 16 (6) · 895

DOI: 10.3390/diagnostics16060895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 18.03.2026. Verfasst von Miloš Veljković und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological developments and Innovations of Republic of Serbia., Ministry of Science, Technological developments and Innovations of Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate Tc-99m-PSMA SPECT/CT detection of biochemical recurrence (BCR) of prostate cancer across serum PSA levels in patients treated with radical prostatectomy or radiation therapy, to explore clinical/pathologic predictors of scan positivity and metastatic disease, and to assess its potential role as a pragmatic alternative when PSMA PET/CT is unavailable in resource-limited settings. Materials and Methods: In this prospective single-center study, we included 132 men with biochemical recurrence who underwent Tc-99m-PSMA SPECT/CT between January 2024 and December 2025 after predefined inclusion and exclusion criteria were applied, and they were further stratified by primary treatment (radical prostatectomy or radiation therapy). Patients were followed up for up to 6 months after imaging to verify observed findings (histopathology, confirmatory imaging and PSA response) and a logistic regression was applied to identify predictors of scan positivity and metastatic disease.

Results

In men initially treated with radical prostatectomy, detection increased from 38.9% at PSA 0.2 to

Schlagwörter

Stichwörter der Autor:innen

Tc-99m-PSMA SPECT/CTbiochemical recurrenceprostate cancer

Autor:innen und Institutionen

  • Center for Nuclear Medicine with PET, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  • Clinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
  • Institute of Medical Statistics and Informatics, 11000 Belgrade, Serbia.

ORCID-Profile: Miloš Veljković, Zoran Bukumirić, Isidora Grozdić-Milojević, Milica Stojiljković, Jelena Petrović, Ana Ivanovski, Dragana Šobić-Šaranović, Vera Artiko

Förderung

  • Ministry of Science, Technological developments and Innovations of Republic of Serbia.
  • Ministry of Science, Technological developments and Innovations of Republic of Serbia

Zitieren

APA

Veljković, M., Beatović, S., Pejčić, T., Bukumirić, Z., Odalović, S., Grozdić-Milojević, I., Stojiljković, M., Petrović, J., Ivanovski, A., Šobić-Šaranović, D., & Artiko, V. (2026). Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study. Diagnostics, 16(6), 895. https://doi.org/10.3390/diagnostics16060895

Vancouver

Veljković M, Beatović S, Pejčić T, Bukumirić Z, Odalović S, Grozdić-Milojević I, et al. Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study. Diagnostics. 2026;16(6):895. doi:10.3390/diagnostics16060895

BibTeX
@article{Veljkovi2026,
  author = {Veljković, Miloš and Beatović, Slobodanka and Pejčić, Tomislav and Bukumirić, Zoran and Odalović, Strahinja and Grozdić-Milojević, Isidora and Stojiljković, Milica and Petrović, Jelena and Ivanovski, Ana and Šobić-Šaranović, Dragana and Artiko, Vera},
  title = {Can Tc-99m-PSMA SPECT/CT Be Used as Accessible Alternative for Diagnosis of Biochemically Recurrent Prostate Cancer? A Prospective Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {895},
  doi = {10.3390/diagnostics16060895}
}
Kostenlos starten →